TPEIR:ATHEXPiraeus Bank S.A. Analysis
Data as of 2026-03-14 - not real-time
€7.30
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Piraeus Bank trades at a trailing P/E of 8.9, well below the industry average of 16.3, and its price‑to‑book sits under 1.0, suggesting the stock is materially undervalued. The dividend yield of 5.45% combined with a modest payout ratio of 36% offers attractive income, while the consensus target price of around €9.8 implies a potential upside of over 30% from the current €7.3 level. The upcoming Capital Markets Day on 5 March will likely provide clarity on the 2026‑2030 strategic plan, adding a catalyst for near‑term price movement.
Technical indicators are mixed: the MACD is bearish and the RSI sits at 42, indicating limited momentum, but the stock is supported around €6.84 and volume is increasing, reducing short‑term downside pressure. Despite a high 30‑day volatility of 55% and a modest beta of 0.47, the bank’s strong cash position (€11.8 bn) relative to debt and a stable regulatory environment keep overall risk moderate, supporting a buy recommendation for medium‑ to long‑term horizons.
Technical indicators are mixed: the MACD is bearish and the RSI sits at 42, indicating limited momentum, but the stock is supported around €6.84 and volume is increasing, reducing short‑term downside pressure. Despite a high 30‑day volatility of 55% and a modest beta of 0.47, the bank’s strong cash position (€11.8 bn) relative to debt and a stable regulatory environment keep overall risk moderate, supporting a buy recommendation for medium‑ to long‑term horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Upcoming Capital Markets Day could shift sentiment
- Support level near €6.84 provides downside cushion
- Bearish MACD and neutral RSI limit upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap versus peers (low P/E, P/B)
- High dividend yield with sustainable payout
- Target price upside of >30% and strategic plan rollout
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Low beta indicating defensive characteristics
- Strong cash buffer relative to debt
- Consistent earnings growth outlook (forward EPS) and dividend stability
Key Metrics & Analysis
Financial Health
Revenue Growth-6.60%
Profit Margin42.75%
P/E Ratio8.9
ROE12.03%
ROA1.24%
P/B Ratio1.0
Op. Cash Flow€-1203000064
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI41.8
Support€6.84
Resistance€8.65
MA 20€7.76
MA 50€8.01
MA 200€7.06
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target Price€9.60
Upside/Downside31.54%
GradeUndervalued
TypeValue
Dividend Yield5.45%
Risk Assessment
Beta0.47
Volatility55.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.